The Antitrust Division of the U.S. Department of Justice has intensified its scrutiny of health care markets by establishing a dedicated task force: the Task Force on Health Care Monopolies and Collusion.
The risks go beyond a suit for an injunction. The Antitrust Division has been coordinating with False Claims Act prosecutors who have sought treble damages in government contracting cases, and the Antitrust Division, of course, has its own criminal authority. This all comes as the Department of Justice (DOJ) is publicizing and expanding available opportunities for individuals to receive cash awards for providing information to the government.
Increased investigations and aggressive enforcement are expected, so it’s important for health care market participants to take proactive measures to review compliance, assess risks, and conduct training.
